Involvement of SULT1A3 in elevated sulfation of 4-hydroxypropranolol in Hep G2 cells pretreated with β-naphthoflavone

Biochemical Pharmacology

Volumn 69, Issue 6, 2005, Pages 941-950

  Miyano, Junko ^a   Yamamoto, Shigeo ^a   Hanioka, Nobumitsu ^a   Narimatsu, Shizuo ^a   Ishikawa, Tsutomu ^b   Ogura, Kenichiro ^c   Watabe, Tadashi ^c   Nishimura, Masuhiro ^d   Ueda, Nobuhiko ^d   Naito, Shinsaku ^d  

^a OKAYAMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

4 Hydroxypropranolol; Hep G2 cell line; SULT1A3; Naphthoflavone

Indexed keywords

4 HYDROXYPROPRANOLOL; BETA NAPHTHOFLAVONE; DOPAMINE; ISOENZYME; LIOTHYRONINE; MESSENGER RNA; RECOMBINANT ENZYME; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1A3; SULFOTRANSFERASE 1B1; SULFOTRANSFERASE 1E1; SULFOTRANSFERASE 2A1; UNCLASSIFIED DRUG;

ARTICLE; CELL FRACTIONATION; CELL KINETICS; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOSOL; DRUG ACTIVITY; DRUG SULFATION; ENANTIOSELECTIVITY; ENZYME INDUCTION; EXAMINATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; RACE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 20044362381     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.12.012     Document Type: Article

References (40)

1. R. Howe, and R.G. Shanks Optical isomers of propranolol Nature 210 1966 1336 1338
2. A.M. Barrett, and V.A. Cullum The biological properties of the optical enantiomers of propranolol and their effects on cardiac arrhythmias Br J Pharmacol 34 1968 43 55
3. A. Hayes, and R.G. Cooper Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey J Pharmacol Exp Ther 176 1971 302 311
4. W.L. Nelson, and M.J. Bartels N-Dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects Drug Metab Dispos 12 1984 345 352
5. T. Walle Stereochemistry of the in vivo disposition and metabolism of propranolol in dog and man using deuterium-labeled pseudoracemates Drug Metab Dispos 13 1985 279 282
6. R.E. Talaat, and W.L. Nelson Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro Drug Metab Dispos 16 1988 207 211
7. T. Walle, U.K. Walle, and L.S. Olanoff Quantitative account of propranolol metabolism in urine of normal man Drug Metab Dispos 13 1985 204 209
8. B.K. Wilson, and J.A. Thompson Glucuronidation of propranolol by dog liver microsomes. Effects of enantiomeric inhibition and detergent treatment on stereoselectivity Drug Metab Dispos 12 1984 161 164
9. D.J. Fitzgerald, and S.R. O'Donnell Pharmacology of 4-hydroxypropranolol Br J Pharmacol 43 1971 222 235
10. Y. Masubuchi, S. Hosokawa, T. Horie, T. Suzuki, S. Ohmori, and M. Kitada Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desispropylase Drug Metab Dispos 22 1994 909 915
11. T. Walle, and U.K. Walle Stereoselective sulfate conjugation of racemic 4-hydroxypropranolol by human and rat liver cytosol Drug Metab Dispos 19 1991 448 453
12. T. Walle Stereoselective sulfate conjugation of 4-hydroxypropranolol and terbutaline by the human liver phenol sulfotransferases Drug Metab Dispos 20 1992 333 336
13. K. Nagata, and Y. Yamazoe Pharmacogenetics of sulfotransferase Annu Rev Pharmacol Toxicol 40 2000 159 176
14. J.A. Shwed, U.K. Walle, and T. Walle Hep G2 cell line as a human model for sulphate conjugation of drugs Xenobiotica 22 1992 973 982
15. T. Walle, U.K. Walle, J.A. Shwed, K.R. Thornburg, C.E. Mathis, and G.R. Pesola Human phenolsulfotransferases: chiral substrates and expression in Hep G2 cells Chem Biol Interact 92 1994 47 55
16. I. Chung, and E. Bresnick 3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma Hep G2 cells as quantified by the reverse transcription-polymerase chain reaction Arch Biochem Biophys 314 1994 75 81
17. S. Narimatsu, T. Watanabe, M. Mochida, Y. Masubuchi, T. Horie, and Y. Kumagai Characterization of a chemically reactive propranolol metabolite that bind to microsomal proteins of rat liver Chem Res Toxicol 8 1995 721 728
18. S. Narimatsu, T. Arai, T. Watanabe, T. Horie, T. Suzuki, and T. Ishikawa Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins in the rat Chem Res Toxicol 10 1997 289 295
19. S. Narimatsu, T. Arai, Y. Masubuchi, T. Horie, M. Hosokawa, and K. Ueno Inactivation of rat cytochrome P4502D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol Biol Pharm Bull 24 2001 988 994
20. J. Miyano, H. Motoyama, M. Fukuoka, S. Yamamoto, S. Narimatsu, and K. Ogura Effects of pretreatment of Hep G2 cells with β-naphthoflavone on cytotoxicity of propranolol and its active metabolite 4-hydroxypropranolol J Health Sci 49 2003 1 6
21. T. Kumamoto, N. Aoyama, S. Nakano, T. Ishikawa, and S. Narimatsu Synthesis of enantiomeric 4-hydroxypropranolols from 1,4-dihydroxynaphthalene Tetrahedron: Asymmetry 12 2001 791 795
22. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
23. K. Ogura, T. Nishiyama, H. Takubo, A. Kato, H. Okuda, and K. Arakawa Suicidal inactivation of human dihydropyrimidine dehydrogenase by (E)-5-(2-bromovinyl)uracil derived from the antiviral, sorivudine Cancer Lett 122 1998 107 113
24. S. Ozawa, K. Nagata, M. Shimada, M. Ueda, T. Tsuzuki, and Y. Yamazoe Primary structures and properties of two related forms of aryl sulfotransferase in human liver Pharmacogenetics 5 1995 S135 S140
25. R.B. Raftogianis, and T.C. Wood Weinshilboum RM human phenol sulfotransferase SULT1A2 and SULT1A1, genetic polymorphisms, allozyme properties and human liver genotype-phenotype correlations Biochem Pharmacol 58 1999 605 616
26. T. Nishiyama, K. Ogura, H. Nakano, T. Kaku, E. Takahashi, and Y. Ohkubo Sulfation of environmental estrogens by cytosolic human sulfotransferases Drug Metab Pharmacokinet 17 2002 221 228
27. S. Narimatsu, N. Kobayashi, K. Asaoka, Y. Masubuchi, T. Horie, and M. Hosokawa High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol Chirality 13 2001 140 147
28. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno A pharmacokinetic analysis program (MULTI) for microcomputer J Pharmacobiol Dyn 4 1981 879 885
29. K. Fujita, F. Nagata, T. Yamazaki, E. Watanabe, M. Shimada, and Y. Yamazoe Enzymatic characterization of human cytosolic sulfotransferases; identification of ST1B2 as a thyroid hormone sulfotransferase Biol Pharm Bull 22 1999 446 452
30. J.L. Falany, V. Krasnykh, G. Mikheeva, and C.N. Falany Isolation and expression of an isoform of rat estrogen sulfotransferase J Steroid Biochem Mol Biol 52 1995 35 44
31. F.P. Guengerich, P. Wang, and N.K. Davidson Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits and humans using immunochemical staining coupled with sodium dodecy sulfate-polyacrylamide gel electrophoresis Biochemistry 21 1982 1698 1706
32. E. Lambertini, L. Penolazzi, G. Aguiari, L. del Senno, F. Pezzetti, and V. Sollazzo Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene Biochem Biophys Res Commun 292 2002 761 770
33. F.P. Limbourg, Z. Huang, J.C. Plumier, T. Simoncini, M. Fujioka, and J. Tuckermann Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids J Clin Invest 110 2002 1729 1738
34. J.R. Dawson, D.J. Adams, and C.R. Wolf Induction of drug metabolizing enzymes in human liver cell line Hep G2 FEBS Lett 183 1985 219 222
35. L. Liu, and C.D. Klaassen Regulation of hepatic sulfotransferases by steroidal chemicals in rats Drug Metab Dispos 24 1996 854 858
36. M. Runge-Morris, K. Rose, and T.A. Kocarek Regulation of rat hepatic sulfotransferae gene expression by glucocorticoid hormones Drug Metab Dispos 24 1996 1095 1101
37. M. Runge-Morris, K. Rose, C.N. Falany, and T.A. Kocarek Differential regulation of individual sulfotransferase isoforms by phenobarbital in male rat liver Drug Metab Dispos 26 1998 795 801
38. M. Runge-Morris Regulation of sulfotransferase gene expression by glucocorticoid hormones and xenobiotics in primary rat hepatocyte culture Chem Biol Interact 109 1998 315 327
39. Z. Duanmu, D. Locke, J. Smigelski, W. Wu, M.S. Dahn, and C.N. Falany Effects of dexamathasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes Drug Metab Dispos 30 2002 997 1004
40. U.K. Walle, and T. Walle Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements Drug Metab Dispos 30 2002 564 569